Symbol | Exchange | Currency |
|---|
Sorrento Therapeutics (SRNE) and Sorrento Mexico announce that Mexican regulatory agency, COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) has...
As COVID-19 cases spike in Mexico, Sorrento Therapeutics Mexico ("Sorrento Mexico") won the first tender offer in 2022 by the Mexico City Government for COVISTIX tests, which were...
Here's a roundup of top developments in the biotech space over the last 24 hours.Stocks In FocusKura Announces Lifting Of Clinical Hold On Phase 1 Blood Cancer StudyKura...
COVID-19 patients with newly diagnosed SARS-CoV-2 infections were treated in these randomized, double-blind, placebo-controlled Phase 2 trials in the US and UK.COVI-DROPS™...
Stock markets are set to finish higher today and that will round off a positive week.EuropeVolatility has been low as the US stock market will close early today. Yesterday the US...
As the world eagerly awaits results for the U.S. Presidential election, there's yet another highly anticipated event: a breakthrough in the coronavirus vaccine.Positive news about...
Sorrento Therapeutics, Inc. is a clinical-stage, antibody-centric, biopharmaceutical company developing therapies to treat cancers and COVID-19. The Company's segments include Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around Immune-Oncology therapeutic area, leveraging its proprietary G-MAB antibody library and targeted delivery modalities to generate the next generation of cancer therapeutics. The Scilex segment is largely organized around its non-opioid pain management operations. The Company's multimodal, multipronged approach to fighting cancer is made possible by immuno-oncology platforms, including key assets such as fully human antibodies, clinical-stage immuno-cellular therapies, antibody-drug conjugates, and clinical-stage oncolytic virus. It is also developing potential antiviral therapies and vaccines against coronaviruses, which includes COVI-GUARD, COVI-AMG, COVI-SHIELD, Gene-MAb, COVI-MSC, and COVI-DROPS.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 509.80 | 513.00 | 483.70 | +15.30 | +3.09% | 2.47M | London | |||
| 306.40 | 312.40 | 304.00 | -5.00 | -1.61% | 377.62K | London | |||
| 203.55 | 207.80 | 200.40 | +1.35 | +0.67% | 27.28M | London | |||
| 300.00 | 302.20 | 294.30 | +4.20 | +1.42% | 14.20M | London | |||
| 104.50 | 104.50 | 100.00 | 0.00 | 0.00% | 1.13M | London | |||
| 193.55 | 195.60 | 188.50 | +2.00 | +1.04% | 32.83M | London | |||
| 435.20 | 436.40 | 421.00 | +4.40 | +1.02% | 3.86M | London | |||
| 636.40 | 667.60 | 630.40 | -51.40 | -7.47% | 2.91M | London | |||
| 102.60 | 103.65 | 100.40 | -1.30 | -1.25% | 8.23M | London | |||
| 1,347.00 | 1,358.00 | 1,310.00 | +26.00 | +1.97% | 1.79M | London | |||
| 213.90 | 217.30 | 212.00 | -0.60 | -0.28% | 3.87M | London | |||
| 635.80 | 646.00 | 617.80 | +0.40 | +0.06% | 5.54M | London | |||
| 2,255.00 | 2,275.00 | 2,225.00 | -39.0 | -1.70% | 315.54K | London | |||
| 3,735.50 | 3,765.50 | 3,636.50 | +91.0 | +2.50% | 4.96M | London | |||
| 1,006.00 | 1,006.50 | 984.00 | +2.00 | +0.20% | 287.56K | London |